[EN] ANTIMICROBIAL COMBINATION THERAPEUTICS<br/>[FR] POLYTHÉRAPIE ANTIMICROBIENNE
申请人:[en]AEQUOR, INC.
公开号:WO2022081594A1
公开(公告)日:2022-04-21
This disclosure relates to organophosphorous and organosulfurous compounds and their use in the amelioration, treatment, and/or prevention of microbial infections and diseases in a subject. The disclosure also relates to combination therapy using a composition comprising organophosphorous compounds, organosulfurous compounds, and antimicrobials in methods for treating or inhibiting microbial infections and diseases.